Charles River Laboratories | CRL - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Agilent USD 7.36B 241M 2026-06
Align Technology USD 4.23B 83.03M 2026-06
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
Bruker USD 2.44B 67M 2026-06
Cardinal Health USD -2.88B 51M 2026-06
Charles River Laboratories USD 2.84B 59.06M 2026-06
Cigna USD 42.62B 410M 2026-06
Concord Medical Services Hldg CNY -2.1B 136.32M 2025-12
CVS Health USD 79.7B 2.25B 2026-06
Danaher USD 52.58B 368M 2026-06
Dentsply International USD 1.35B 33M 2026-06
Elevance Health USD 44.88B 981M 2026-06
Humana USD 19.21B 633M 2026-06
Illumina USD 2.84B 162M 2026-06
Incyte USD 6.34B 721.58M 2026-06
Intrexon USD 43.17M 75.33M 2024-06
IQVIA Holdings USD 6.17B 50M 2026-06
Laboratory Of America USD 8.61B 121.8M 2026-06
Lakefront Biotherapeutics EUR 3.26B 10.26M 2026-06
Lonza CHF 9.13B 513M 2025-12
McKesson USD -4.24B 2.07B 2026-06
Merck EUR 30.17B 430M 2026-06
Mettler Toledo International USD 12.82M 54.71M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Quest Diagnostics USD 7.52B 150M 2026-06
Revvity USD 7.18B 67.62M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
United Therapeutics USD 6.4B 499.2M 2026-06
UnitedHealth USD 105.32B 3.62B 2026-03
Veradigm USD 1.02B 159.52M 2022-12
Waters USD 15.29B 12.73B 2026-03
West Pharmaceutical Services USD 2.99B 200K 2026-06